Impact Of Neurological Disorders On Implantable Pulse Generator Market Growth: Transformative Forces Shaping the Implantable Pulse Generator Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Implantable Pulse Generator Industry Market Size Be by 2025?
The market size for implantable pulse generators has experienced substantial growth in the past few years. In 2024, it was valued at $133.75 billion and is projected to reach $147.01 billion in 2025, with a compound annual growth rate (CAGR) of 9.9%. The remarkable growth during the historic period is due to a myriad of factors including the proliferation of home healare facilities, increased adoption of neuromodulation in managing diseases, improved patient diagnoses, heightened usage of medical devices, and better patient awareness.

What's the Long-Term Growth Forecast for the Implantable Pulse Generator Market Size Through 2029?
Anticipated to experience swift expansion in the coming years, the implantable pulse generator market is projected to reach $221.62 billion by 2029, registering a compound annual growth rate (CAGR) of 10.8%. This surge during the forecast period can be credited to factors such as the rise in health care spending, preference of patients for less invasive treatments, beneficial reimbursement policies, expansion in application domains, and the increasing use of implants in therapies. Key trends expected during the forecast period involve the shrinking size of devices, improved battery life, the advent of wireless connectivity and smart implantable tools, as well as the incorporation of artificial intelligence and machine learning.

View the full report here:
https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report

What Are the Key Growth Drivers Fueling the Implantable Pulse Generator Market Expansion?
The upsurge in cases of neurological conditions is predicted to stimulate the expansion of the implantable pulse generator market. Neurological conditions involve disorders affecting the brain, spinal cord and nervous systems which can affect functions like movement, sensation and cognition. The growing prevalence of these disorders can be linked to factors including ageing populations, changes in lifestyle, environmental factors and advancements in diagnostic methods. Implantable pulse generators can assist with neurological disorders by transmitting precise electrical impulses to regulate abnormal neural activity and ease symptoms. For example, the Parkinson Foundation, a nonprofit organization based in the U.S., reported in December 2022 that by 2020, 930,000 individuals in the U.S. were suffering from Parkinson's disease (PD), and it is projected that this figure will rise to 1.2 million by 2030. Hence, the increase in cases of neurological disorders is promoting the expansion of the implantable pulse generator market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18639&type=smp

What Trends Will Shape the Implantable Pulse Generator Market Through 2029 and Beyond?
Major firms in the implantable pulse generator market are shifting their attention towards creating innovative neuromodulation devices to boost treatment effectiveness, enhance patient results, and extend these devices application to a wider variety of neurological disorders. Neuromodulation devices are medical tools designed to change nerve function by delivering electrical or pharmaceutical substances directly to precise areas of the nervous system. For example, CVRx Inc., a medical device company based in the US, launched the new Barostim NEO2 IPG, an implantable pulse generator targeting therapy patients, in November 2022. The Barostim system makes use of neuromodulation to better heart failure indicators by delivering electrical impulses to the baroreceptors in the wall of the carotid artery. These signals activate the body's baroreflex, initiating an automatic response in the heart. The aim of this therapy is to reestablish equilibrium in the autonomic nervous system and lessen heart failure symptoms.

How Is the Implantable Pulse Generator Market Segmented?
The implantable pulse generator market covered in this report is segmented -

1) By Product: Implantable Cardiac Pacemakers, Implantable Defibrillators, Cochlear Implants, Implantable Nerve Stimulators (Fes), Implantable Infusion Pumps, Implantable Active Monitoring Devices
2) By Charging Type: Rechargeable, Non Rechargeable
3) By Application: Cardiovascular Diseases, Movement Disorders, Orthopedic Diseases, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics

Subsegments:
1) By Implantable Cardiac Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers
2) By Implantable Defibrillators: Implantable Cardioverter Defibrillators (ICD), Subcutaneous Implantable Defibrillators (S-ICD)
3) By Cochlear Implants: Single-Channel Cochlear Implants, Multi-Channel Cochlear Implants
4) By Implantable Nerve Stimulators (Fes): Functional Electrical Stimulation (FES) Devices For Motor Function Restoration, Spinal Cord Stimulation Devices
5) By Implantable Infusion Pumps: Insulin Pumps, Pain Management Pumps, Intrathecal Drug Delivery Pumps
6) By Implantable Active Monitoring Devices: Continuous Glucose Monitoring Systems, Cardiac Monitoring Devices, Neurological Monitoring Devices

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18639&type=smp

Which Companies Are Leading the Charge in Implantable Pulse Generator Market Innovation?
Major companies operating in the implantable pulse generator market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Integer Holdings Corporation, Livanova plc, Inspire Medical Systems Inc., Nevro Corp, Impulse Dynamics Ltd., Valtronic Inc., NeuroPace Inc., SPR Therapeutics Inc., Stimwave LLC, SetPoint Medical, ReShape Lifesciences Inc., Synapse Biomedical Inc., Nuvectra Medical Inc., NeuroSigma Inc., Nalu Medical Inc., MainStay Medical International PLC, Dextronix Inc., BioControl Medical Inc.

Which Regions Are Leading the Global Implantable Pulse Generator Market in Revenue?
North America was the largest region in the implantable pulse generator market in 2024. The regions covered in the implantable pulse generator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18639

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.